Elbert Huang to Hypoglycemic Agents
This is a "connection" page, showing publications Elbert Huang has written about Hypoglycemic Agents.
Connection Strength
5.914
-
Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Med Decis Making. 2019 02; 39(2):137-151.
Score: 0.546
-
Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications. Health Aff (Millwood). 2018 08; 37(8):1200-1207.
Score: 0.529
-
Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
Score: 0.506
-
Management of diabetes mellitus in older people with comorbidities. BMJ. 2016 06 15; 353:i2200.
Score: 0.456
-
Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs. J Manag Care Spec Pharm. 2015 Dec; 21(12):1214-34.
Score: 0.439
-
Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010 Sep; 12(9):679-84.
Score: 0.305
-
Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009 Feb; 32(2):311-6.
Score: 0.270
-
The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006 Feb; 29(2):259-64.
Score: 0.222
-
Individualizing Care for Older Adults With Diabetes Amid the Revolution in Pharmacotherapy. JAMA Intern Med. 2024 Apr 01; 184(4):435-436.
Score: 0.196
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 04; 176(4):eL230007.
Score: 0.183
-
The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence. J Cardiovasc Transl Res. 2012 Aug; 5(4):380-7.
Score: 0.171
-
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med. 2001 Dec 01; 111(8):633-42.
Score: 0.167
-
The Cost and Safety of Insulin in Older Adults. JAMA Intern Med. 2021 05 01; 181(5):608-609.
Score: 0.160
-
Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
Score: 0.145
-
Approaches to Risk Assessment Among Older Patients With Diabetes. Curr Diab Rep. 2019 07 19; 19(8):59.
Score: 0.141
-
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
Score: 0.131
-
Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care. 2018 06; 41(6):1227-1234.
Score: 0.129
-
Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017 10 01; 177(10):1461-1470.
Score: 0.125
-
Physician perspectives on de-intensifying diabetes medications. Medicine (Baltimore). 2016 Nov; 95(46):e5388.
Score: 0.117
-
Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus. J Am Geriatr Soc. 2017 01; 65(1):77-82.
Score: 0.116
-
Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA. 2016 Apr 05; 315(13):1400-2.
Score: 0.113
-
Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health (Larchmt). 2013 Dec; 22(12):1049-55.
Score: 0.094
-
Medication use in older U.S. adults with diabetes mellitus and the potential ramifications of raising the glycemic target. J Am Geriatr Soc. 2011 Dec; 59(12):2381-3.
Score: 0.083
-
The risks and benefits of implementing glycemic control guidelines in frail older adults with diabetes mellitus. J Am Geriatr Soc. 2011 Apr; 59(4):666-72.
Score: 0.080
-
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 02; 359(14):1464-76.
Score: 0.067
-
JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther. 2008 Aug; 10(4):310-21.
Score: 0.066
-
Appropriate application of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev. 2007 Nov; 3(4):260-3.
Score: 0.063
-
Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study. J Am Geriatr Soc. 2023 12; 71(12):3692-3700.
Score: 0.047
-
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
Score: 0.044
-
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
Score: 0.041
-
Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2017 12; 40(12):1661-1667.
Score: 0.031
-
Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care. 2016 Feb; 39(2):308-18.
Score: 0.028
-
Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
Score: 0.026
-
Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012 Dec; 60(12):2342-56.
Score: 0.022
-
Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care. 2010 Oct; 33(10):2175-7.
Score: 0.019
-
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009 Nov; 32(11):1947-53.
Score: 0.018
-
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009 Aug; 32(8):1378-83.
Score: 0.017